Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alanvin Orpia"'
Autor:
V. Koneti Rao, Sharon Webster, Anna Sediva, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A.S.H. Dalm, Antonino Trizzino, Yulia Zharankova, Elaine Kulm, Alanvin Orpia, Lavenda Chirombo Kluczynski, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Klaus Kucher, Kath Radford, Jason Bradt, Gulbu Uzel
Publikováno v:
Blood. 140:1643-1645
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Purpose:BN-CV301 is a poxviral-based vaccine comprised of recombinant (rec.) modified vaccinia Ankara (MVA-BN-CV301; prime) and rec. fowlpox (FPV-CV301; boost). Like its predecessor PANVAC, BN-CV301 contains transgenes encoding tumor-associated antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3f5b25865fb0afb72c49d7fca8cbf1
https://doi.org/10.1158/1078-0432.c.6528519
https://doi.org/10.1158/1078-0432.c.6528519
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Supplementary Table S1A: Phenotypic analysis of surface markers on human DCs transfected with MVA-BN-CV301 and FPV-CV301 vectors Supplementary Table S1B: Activation of CEA- and MUC1-specific T-cells by MVA-BN-CV301 and FPV-CV301 Supplementary Table S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a56f2d1ae1207bb367dea6c1ad6c8e4
https://doi.org/10.1158/1078-0432.22473483.v1
https://doi.org/10.1158/1078-0432.22473483.v1
Autor:
Cesar Pico Navarro, Julius Strauss, Jaydira Del Rivero, Eva M. Wagner, Ravi A. Madan, Alanvin Orpia, Christopher R. Heery, Claudia Palena, James L. Gulley, Elizabeth Lamping, Lisa M. Cordes, Margaret E. Gatti-Mays, Jason M. Redman, Jennifer L. Marte, Andrea Burmeister, Renee N. Donahue, Jeffrey Schlom
Publikováno v:
Clinical Cancer Research. 25:4933-4944
Purpose: BN-CV301 is a poxviral-based vaccine comprised of recombinant (rec.) modified vaccinia Ankara (MVA-BN-CV301; prime) and rec. fowlpox (FPV-CV301; boost). Like its predecessor PANVAC, BN-CV301 contains transgenes encoding tumor-associated anti
Autor:
Julius Strauss, Jeffrey Schlom, Andrea Burmeister, Ravi A. Madan, Lisa M. Cordes, Seth M. Steinberg, Marijo Bilusic, Margaret E. Gatti-Mays, Fatima Karzai, Claudia Palena, James L. Gulley, Jason M. Redman, Alanvin Orpia, Jennifer L. Marte, Renee N. Donahue, Houssein Abdul Sater, Sheri McMahon
Publikováno v:
The Oncologist
Lessons Learned Concurrent ETBX-011, ETBX-051, and ETBX-061 can be safely administered to patients with advanced cancer. All patients developed CD4+ and/or CD8+ T-cell responses after vaccination to at least one tumor-associated antigen (TAA) encoded
Autor:
James L. Gulley, Cesar Pico, Margaret E. Gatti-Mays, Alanvin Orpia, Christopher R. Heery, Julius Strauss, Arun Rajan, Eva Wagner
Publikováno v:
Journal of Clinical Oncology. 36:TPS9108-TPS9108
TPS9108Background: Despite recent therapeutic advances in non-small cell lung cancer (NSCLC), an unmet medical need remains for most patients. Pembrolizumab (pembro) is approved in first-line treat...